Suppr超能文献

提供者所感知到的患者在坚持结直肠癌筛查方面的障碍。

Provider-perceived barriers to patient adherence to colorectal cancer screening.

作者信息

Zhu Xuan, Weiser Emily, Jacobson Debra J, Griffin Joan M, Limburg Paul J, Finney Rutten Lila J

机构信息

Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Healthcare Delivery, Rochester, MN, USA.

Exact Sciences Corporation, Madison, WI, USA.

出版信息

Prev Med Rep. 2021 Dec 27;25:101681. doi: 10.1016/j.pmedr.2021.101681. eCollection 2022 Feb.

Abstract

BACKGROUND

Average-risk colorectal cancer (CRC) screening remains underutilized in the US. Provider recommendation is strongly associated with CRC screening completion. To inform interventions aimed at improving screening uptake, we examined providers' perspectives on patient and health system barriers to CRC screening adherence, along with associated system-level interventions to improve uptake.

METHODS

We conducted an online survey between November and December 2019 with a sample of primary care clinicians (PCCs) and gastroenterologists (GIs) from a validated panel of US clinicians (814 PCCs, 159 GIs; completion rates: 25.3% for PCCs, 29.6% for GIs). Clinicians rated the extent to which each patient and health system factor interferes with patient adherence with CRC screening recommendations and the availability of practice interventions to improve screening rates.

RESULTS

Provider-reported top barriers to CRC screening included patient discomfort with offered screening method (66%), cost (62-64%), and perceived low importance of screening (62%). Additional barriers included providers prioritizing urgent health concerns over screening (45-48%), not offering a choice of screening options (42-48%), lacking time to educate patients about screening (38-45%), and lacking education about available screening options (37-40%). Most frequently reported system-level interventions to improve CRC screening rates included patient education materials (57-62%) and point of care prompts (56-61%). Other interventions were less frequently reported, although variations existed by clinical specialty regarding barriers and interventions.

CONCLUSIONS

Addressing barriers to CRC screening requires system-level interventions, including provider training on shared decision-making, automated scheduling and reminder processes, and policies to increase clinician time for preventive screening consultations.

摘要

背景

在美国,平均风险的结直肠癌(CRC)筛查的利用率仍然较低。医生的建议与CRC筛查的完成情况密切相关。为了为旨在提高筛查接受率的干预措施提供信息,我们研究了医生对患者和卫生系统阻碍CRC筛查依从性的看法,以及相关的系统层面干预措施以提高接受率。

方法

我们在2019年11月至12月期间对来自美国经过验证的临床医生小组的初级保健临床医生(PCC)和胃肠病学家(GI)进行了在线调查(814名PCC,159名GI;完成率:PCC为25.3%,GI为29.6%)。临床医生对每个患者和卫生系统因素干扰患者遵循CRC筛查建议的程度以及提高筛查率的实践干预措施的可用性进行了评分。

结果

医生报告的CRC筛查的主要障碍包括患者对所提供的筛查方法感到不适(66%)、成本(62 - 64%)以及认为筛查重要性低(62%)。其他障碍包括医生将紧急健康问题置于筛查之上(45 - 48%)、不提供筛查选项的选择(42 - 48%)、缺乏时间对患者进行筛查教育(38 - 45%)以及缺乏对可用筛查选项的了解(37 - 40%)。最常报告的提高CRC筛查率的系统层面干预措施包括患者教育材料(57 - 62%)和即时护理提示(56 - 61%)。其他干预措施的报告频率较低,尽管不同临床专业在障碍和干预措施方面存在差异。

结论

解决CRC筛查的障碍需要系统层面的干预措施,包括对医生进行共同决策培训、自动化预约和提醒流程,以及增加临床医生进行预防性筛查咨询时间的政策。

相似文献

1
Provider-perceived barriers to patient adherence to colorectal cancer screening.
Prev Med Rep. 2021 Dec 27;25:101681. doi: 10.1016/j.pmedr.2021.101681. eCollection 2022 Feb.
3
Health Care Provider Characteristics Associated With Colorectal Cancer Screening Preferences and Use.
Mayo Clin Proc. 2022 Jan;97(1):101-109. doi: 10.1016/j.mayocp.2021.06.028. Epub 2021 Dec 14.
5
Patient-Provider Communication and Colorectal Cancer Screening Completion Using Multi-target Stool DNA Testing.
J Cancer Educ. 2025 Feb;40(1):115-123. doi: 10.1007/s13187-024-02479-w. Epub 2024 Jul 20.
8
Barriers to Colorectal Cancer Screening in a Racially Diverse Population Served by a Safety-Net Clinic.
J Community Health. 2017 Aug;42(4):791-796. doi: 10.1007/s10900-017-0319-6.
9
Factors influencing colorectal cancer screening decision-making among average-risk US adults.
Prev Med Rep. 2022 Nov 7;30:102047. doi: 10.1016/j.pmedr.2022.102047. eCollection 2022 Dec.

引用本文的文献

1
Barriers to cancer screening uptake and approaches to overcome them: a systematic literature review.
Front Oncol. 2025 Aug 6;15:1575820. doi: 10.3389/fonc.2025.1575820. eCollection 2025.
2
3
5
Racial and sociodemographic distribution of colorectal cancer screening in Canada: A cross-sectional study.
Can J Public Health. 2024 Jun;115(3):371-383. doi: 10.17269/s41997-024-00859-9. Epub 2024 Mar 14.
7
The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.
Cell Rep Med. 2023 Oct 17;4(10):101198. doi: 10.1016/j.xcrm.2023.101198. Epub 2023 Sep 15.

本文引用的文献

1
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2021 May 18;325(19):1965-1977. doi: 10.1001/jama.2021.6238.
2
Vital Signs: Colorectal Cancer Screening Test Use - United States, 2018.
MMWR Morb Mortal Wkly Rep. 2020 Mar 13;69(10):253-259. doi: 10.15585/mmwr.mm6910a1.
3
Colorectal cancer statistics, 2020.
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
5
Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society.
CA Cancer J Clin. 2018 Jul;68(4):250-281. doi: 10.3322/caac.21457. Epub 2018 May 30.
6
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cancer. 2018 Jul 1;124(13):2785-2800. doi: 10.1002/cncr.31551. Epub 2018 May 22.
8
Impact of provider-patient communication on cancer screening adherence: A systematic review.
Prev Med. 2016 Dec;93:96-105. doi: 10.1016/j.ypmed.2016.09.034. Epub 2016 Sep 28.
9
Systematic Review and Meta-study Synthesis of Qualitative Studies Evaluating Facilitators and Barriers to Participation in Colorectal Cancer Screening.
Cancer Epidemiol Biomarkers Prev. 2016 Jun;25(6):907-17. doi: 10.1158/1055-9965.EPI-15-0990. Epub 2016 Apr 13.
10
Colorectal cancer screening: a global overview of existing programmes.
Gut. 2015 Oct;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. Epub 2015 Jun 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验